These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22865186)

  • 1. Alzheimer's disease biomarkers.
    Chiu HF; Li SW
    Hong Kong Med J; 2012 Aug; 18(4):351-2; author reply 352. PubMed ID: 22865186
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease: early diagnosis and treatment.
    Chu LW
    Hong Kong Med J; 2012 Jun; 18(3):228-37. PubMed ID: 22665688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
    Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
    Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination therapy no advantage in Alzheimer's treatment.
    Harv Health Lett; 2012 Jun; 37(8):8. PubMed ID: 22774260
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
    Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
    [No Abstract]   [Full Text] [Related]  

  • 6. Questions & answers. We've been told that my wife has multi-infarct dementia and that the new drug memantine may help. How is her condition different from Alzheimer's disease, and what could memantine do for her?
    Miller MC
    Harv Ment Health Lett; 2004 Mar; 20(9):8. PubMed ID: 15044129
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies.
    Cummings JL
    Rev Neurol Dis; 2007; 4(2):57-62. PubMed ID: 17609636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005].
    Wellhöfer B
    Dtsch Med Wochenschr; 2006 Feb; 131(6):284. PubMed ID: 16463237
    [No Abstract]   [Full Text] [Related]  

  • 9. I remember.
    Ladouceur R
    Can Fam Physician; 2006 Feb; 52():155. PubMed ID: 16529383
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer Disease: Monotherapy vs. Combination Therapy.
    Lawler E; Avila A
    Am Fam Physician; 2017 Apr; 95(7):452. PubMed ID: 28409590
    [No Abstract]   [Full Text] [Related]  

  • 11. Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France.
    Hommet C; Novella JL; Auriacombe S; Vercelletto M; Berrut G; Belliard S; Desmidt T; Ceccaldi M
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):274-86. PubMed ID: 27651009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of memantine for the treatment of dementia.
    Lo D; Grossberg GT
    Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for Alzheimer disease.
    Can Fam Physician; 2005 Nov; 51(11):1485. PubMed ID: 16353830
    [No Abstract]   [Full Text] [Related]  

  • 14. Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.
    Kerchner GA; Tartaglia MC; Boxer A
    Expert Rev Neurother; 2011 May; 11(5):709-17. PubMed ID: 21728274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia.
    Rodda J; Carter J
    BMJ; 2012 May; 344():e2986. PubMed ID: 22550350
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological treatment of dementia.
    Schwarz S; Froelich L; Burns A
    Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease.
    Gauthier S; Molinuevo JL
    Alzheimers Dement; 2013 May; 9(3):326-31. PubMed ID: 23110864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL; Lladó Plarrumaní A
    Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine for patients with Alzheimer disease.
    Finucane TE
    JAMA; 2004 Apr; 291(14):1695; author reply 1695. PubMed ID: 15082684
    [No Abstract]   [Full Text] [Related]  

  • 20. A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil.
    van Dyck CH; Schmitt FA; Olin JT;
    Am J Geriatr Psychiatry; 2006 May; 14(5):428-37. PubMed ID: 16670247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.